You may contact an individual director, the lead director or the full board of IDEXX Laboratories, Inc., by addressing communications to the Office of the General Counsel at contactdirectors@idexx.com or to the following address:
IDEXX Laboratories, Inc.
Board of Directors
Attn: Office of the General Counsel
One IDEXX Drive
Westbrook, Maine 04092
You may report accounting, internal control or audit concerns through our Business Conduct Alert form.
We are proud of our history of strong corporate governance practices, and we seek to maintain the highest standards of ethics while building value for all of our stakeholders.
Executive Officers
IDEXX’s executive officers are appointed by the Board of Directors to carry out the Board’s policies and manage the daily affairs of the Company.
Jonathan W. Ayers has served as Chairman, President and CEO of IDEXX Laboratories, Inc., since January 2002.
Before joining IDEXX, from 1999 to 2001, Mr. Ayers served as President of Carrier Corporation, the then-largest business unit of United Technologies Corporation, and from 1997 to 1999 he was President of Carrier’s Asia Pacific Operations. From 1995 to 1997, Mr. Ayers was Vice President, Strategic Planning at United Technologies. Before joining United Technologies, from 1986 to 1995, Mr. Ayers held various positions at Morgan Stanley & Co. in mergers and acquisitions and corporate finance. Prior to Morgan Stanley, Mr. Ayers was a strategy consultant for Bain & Company from 1983 to 1986 and was in the field sales organization of IBM’s Data Processing Division from 1978 to 1981.
Mr. Ayers holds a bachelor’s degree in molecular biophysics and biochemistry from Yale University, and a master’s in business administration from Harvard University.
Senior Vice President and Chief Scientific Officer
Dr. Wallen has been Senior Vice President and Chief Scientific Officer of the Company since September 2003 and has been leading the Company’s infectious disease product manufacturing operations since December 2008. He led the Company’s pharmaceutical products business from September 2003 until the Company sold certain product lines and restructured that business in 2008.
Before joining the Company, Dr. Wallen was Senior Vice President and Head of the Office of Technology for the Diagnostics Division of Bayer Healthcare. In his ten years with Bayer, Dr. Wallen held various senior scientific and leadership positions, including Head of Research and Development for Bayer's laboratory testing and Head of Research for the nucleic acid diagnostics segment.
Dr. Wallen earned his bachelor’s degree in zoology and his master’s in microbiology from Michigan State University and his doctorate in molecular biology from the University of Arizona College of Medicine. He has authored or co-authored more than 50 scientific papers and articles covering topics in immunology, virology, oncology and detection methodologies.
Corporate Vice President, Instrument Research and Development and Manufacturing
William E. Brown, III, PhD
Corporate Vice President, Instrument Research and Development and Manufacturing
Dr. Brown became a Corporate Vice President of the Company in December, 2008 and oversees the Company’s Instrument Research and Development and Manufacturing operations. Before joining the Company, Dr. Brown was a Corporate Officer and Vice President of R&D, Assays and Instrument Systems for the Diagnostic Division of Abbott Laboratories, Inc. Most recently he was responsible for R&D portfolio development, new product launches, and basic research for immunoassay, clinical chemistry and instrument systems. In his twenty-five years with Abbott, Dr. Brown held various senior leadership positions, developing in-depth expertise in product development, manufacturing, and quality assurance for both life science and instrument systems.
Dr. Brown earned his bachelor’s degree in chemistry education from Indiana University of Pennsylvania and his doctorate in medicinal chemistry from the University of Pittsburgh, School of Pharmacy.
Corporate Vice President, General Counsel and Secretary
Conan R. Deady
Corporate Vice President, General Counsel and Secretary
Mr. Deady has been Corporate Vice President and General Counsel of the Company since August 1999, and has been leading the Company’s business development activities since April 2005 and its regulatory functions since October 2008. Mr. Deady was Deputy General Counsel of the Company from June 1997. Before joining the Company in June 1997, Mr. Deady was Deputy General Counsel of Thermo Electron Corporation (now Thermo Fisher Scientific, Inc.), a provider of analytical and laboratory products and services. Mr. Deady was previously affiliated with Hale and Dorr, a Boston law firm.
Mr. Deady received his B.A. from Amherst College and his J.D. from the University of Virginia.
Mr. Dupree has been a Corporate Vice President of the Company since September 2006, and has been leading the Companion Animal Group Customer Facing Organization in North America since January 2007. He served as Vice President and General Manager of the Rapid Assay business from April 2005 through January 2007, and served as Vice President of Business Development since starting with the Company in March 2003. Prior to joining IDEXX, Mr. Dupree spent seven years at the Boston Consulting Group (BCG), a business strategy consulting firm, and four years with Bath Iron Works in various management and supervisory capacities.
Mr. Dupree received his undergraduate degree from Colby College, majoring in economics and German, and received an MBA from the University of Virginia.
Corporate Vice President, Production Animal Services, Water and Dairy
William B. Goodspeed
Corporate Vice President, Production Animal Services, Water and Dairy
Mr. Goodspeed joined IDEXX in July 2007 as Corporate Vice President and oversees the Company’s Production Animal, Water and Dairy businesses. Prior to joining the Company, from 1994 to 2007, Mr. Goodspeed held various positions at J.M. Huber Corporation, a privately held company in the chemicals, food ingredients, building products, energy and timber industries, most recently as Sector CEO for Natural Resources and Technology-based Services. He previously held the position of President of Huber’s Engineered Woods. Before joining Huber, Mr. Goodspeed served as Executive Vice President of Japan-based Pasona International, managing their non-Japanese businesses of the Pasona Group. He also spent three years as a consultant with McKinsey & Company, and three years as an attorney.
Mr. Goodspeed graduated from Dartmouth College and received his JD from the University of Michigan.
Mr. Meyaard became a Corporate Vice President of the Company in September, 2009, and oversees Worldwide Operations. Before joining IDEXX, Mr. Meyaard held various leadership positions over the course of 29 years at Bayer/Siemens, the world’s largest clinical diagnostics company. Most recently Mr. Meyaard was Vice President of Global Instrument Manufacturing for Siemens Medical Solutions Diagnostics. Prior to that, he served as Vice President for a number of operations, including OEM Reagents and Consumables, Global OEM Management, and Global Strategic Procurement.
Mr. Meyaard earned his bachelor’s degree in chemistry from Calvin College in Grand Rapids, Michigan.
Dr. Naqui has been Corporate Vice President of the Company since January 2006 and has overseen the Company’s international commercial operations since December 2007 and its Asia Pacific and Latin American operations since January 2006. Dr. Naqui led the Company’s Water and Dairy businesses from January 2000 to December 2007. He was General Manager, Water from September 1997 to January 2000, and Director of Research and Development from February 1993 to September 1997. Dr. Naqui joined the Company in 1993 as a result of its acquisition of Environetics, where he was the Director of Research and Development. Prior to joining Environetics, he was a Research and Development manager with Becton, Dickinson and Company.
Dr. Naqui received his PhD from the Department of Chemical Enzymology at Moscow State University. He received his post-doctoral training at the Department of Biochemistry and Biophysics at the University of Pennsylvania.
Mr. Polewaczyk joined IDEXX as Corporate Vice President of the Company in February 2007 and oversees the Company’s Rapid Assay and Digital businesses. Mr. Polewaczyk came to IDEXX from Philips Medical Systems, a subsidiary of Royal Philips Electronics, The Netherlands, where he was General Manager, Medical Consumables and Sensors Business. Prior to Philips, Mr. Polewaczyk spent 15 years at Hewlett-Packard, holding a variety of senior marketing and product development positions in their Medical Products Group.
Mr. Polewaczyk holds a bachelor’s degree in electrical engineering from Worcester Polytechnic Institute and a master’s degree in business from Boston University.
Dr. Powers joined IDEXX as Corporate Vice President in February 2009 to oversee the Company’s worldwide reference laboratories business. Prior to joining the Company, Dr. Powers was Vice President responsible for the Cancer Diagnostics business of Becton Dickinson and Company from 2007 to 2008. Dr. Powers came to Becton Dickinson as a result of its acquisition in 2007 of TriPath Imaging Inc., where he held various positions from 2001 to 2007, most recently serving as President, TriPath Oncology business unit. Prior to joining Tripath, Dr. Powers was employed for five years by Ventana Medical Systems, most recently as Vice President and General Manager of Manufacturing Operations. Before that, he spent seven years in various technical manufacturing roles at Organon Teknika Corporation.
Dr. Powers holds a PhD in biochemical engineering from North Carolina State University, an MBA from the Duke University Fuqua School of Business, an MS in chemical engineering from Clemson University, and a BA in chemistry from Wake Forest University.
Corporate Vice President, Chief Financial Officer and Treasurer
Merilee Raines
Corporate Vice President, Chief Financial Officer and Treasurer
Ms. Raines became Chief Financial Officer of the Company in October 2003. Ms. Raines was Corporate Vice President of Finance of the Company starting in May 1995, Vice President and Treasurer of Finance from March 1995 to May 1995, Director of Finance from 1988 to March 1995, and Controller from 1985 to 1988.
Ms. Raines earned a bachelor’s degree in mathematics from Bowdoin College and an MBA from the University of Chicago.
Dr. Williams became a Corporate Vice President of the Company in September 2006 and has been General Manager of the Companion Animal Instrument and Consumables business since 2004. Dr. Williams has also supervised the OPTI Medical Systems business since its acquisition in February 2007. Dr. Williams joined IDEXX in January of 2003 as Vice President and General Manager of the Company’s chemistry instruments and consumables business. Prior to joining IDEXX, Dr. Williams worked as a Senior Research Associate at the Scripps Research Institute, Department of Vascular Biology, for several years and then joined McKinsey & Company for seven years as a healthcare strategy consultant.
Dr. Williams received his bachelor’s degree in biochemistry from the University of Bristol, United Kingdom, and his doctorate in biochemistry from Wadham College, University of Oxford, United Kingdom.
